MedTrace Logo

Carotid Ultrasound Study

NCT02001350 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2016-10-17

No results posted yet for this study

Summary

To use carotid ultrasound to screen 20-30 patients with longstanding or resistant hypertension for carotid atherosclerotic disease and bifurcation anatomy. This will establish a screening protocol for Cibiem's eventual endovascular carotid body modulation trial and will give insight into the prevalence and specific location of carotid plaque at the bifurcation in this patient population.

Conditions

  • Resistant Hypertension

Interventions

OTHER

Ultrasonography

Sponsors & Collaborators

  • Cibiem, Inc.

    collaborator INDUSTRY

  • Noblewell

    lead INDUSTRY

Principal Investigators

  • Paul A. Sobotka, MD · Cibiem, Inc.

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02001350 on ClinicalTrials.gov